David Scott Moore's most recent trade in Corvus Pharmaceuticals Inc was a trade of 21,700 Common Stock done at an average price of $11.5 . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharma Inc | David Scott Moore | Director | Purchase of securities on an exchange or from another person at price $ 11.53 per share. | 11 Jun 2026 | 21,700 | 21,700 (0%) | 0% | 11.5 | 250,236 | Common Stock |
| Corvus Pharma Inc | David Scott Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharma Inc | David Scott Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |